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We have previously demonstrated that over-expression of spike protein (S) of severe acute respiratory syndrome coronavirus (SARS-CoV) or
its C-terminal subunit (S2) is sufficient to induce apoptosis in vitro. To further investigate the possible roles of S2 in SARS-CoV-induced
apoptosis and pathogenesis of SARS, we characterized the host expression profiles induced upon S2 over-expression in Vero E6 cells by
oligonucleotide microarray analysis. Possible activation of mitochondrial apoptotic pathway in S2 expressing cells was suggested, as evidenced by
the up-regulation of cytochrome c and down-regulation of the Bcl-2 family anti-apoptotic members. Inhibition of Bcl-2-related anti-apoptotic
pathway was further supported by the diminution of S2-induced apoptosis in Vero E6 cells over-expressing Bcl-xL. In addition, modulation of
CCN E2 and CDKN 1A implied the possible control of cell cycle arrest at G1/S phase. This study is expected to extend our understanding on the
pathogenesis of SARS at a molecular level.
© 2007 Elsevier Inc. All rights reserved.Keywords: Severe acute respiratory syndrome coronavirus; Spike protein; Apoptosis; Proliferation; MicroarrayIntroduction
Severe acute respiratory syndrome (SARS) is a highly
contagious disease caused by a member of the Coronaviridae
family named SARS Coronavirus (SARS-CoV) (Drosten et al.,
2003; Ksiazek et al., 2003; Peiris, 2003). The disease was first
documented during late 2002 and the outbreak was effectively
controlled by mid-2003 through rigorous quarantine measures
(Zhong et al., 2003). However, the ability of the virus in
infecting multiple cell types (Hattermann et al., 2005; Kaye,
2006) and animals (Martina et al., 2003) implied the risk of viral
circulation in animal reservoirs and hence the re-emergence of
the virus in human population. Understanding the molecular
mechanisms of viral pathogenesis may provide important⁎ Corresponding author. Fax: +852 28574672.
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doi:10.1016/j.virol.2007.09.016information for rational design of antiviral drugs, which may
be important to combat against another possible SARS
epidemic. The viral–host factors contributing to the pathogen-
esis of SARS-CoV are incompletely understood. In addition to
respiratory tract illness, lymphoid depletion in spleen and
lymph nodes is a common clinical manifestation in fatal cases of
SARS (Wong et al., 2003). Cytokine overdrive and apoptosis
induced by the virus were suggested to contribute to such
lymphoid depletion (Wong et al., 2003). These observations,
together with the fact that SARS-CoV is capable to induce
apoptosis in the viral susceptible Vero E6 cell line (Yan et al.,
2004), highlighted the important role of apoptosis in the patho-
genesis of SARS.
The SARS-CoV spike protein (S) is a class I fusion protein.
Cellular entry of the virus was demonstrated to be mediated by
S through the receptor binding domain located in the N-terminal
subunit (S1) (Dimitrov, 2004; Hofmann and Pohlmann, 2004)
and the fusion peptide in the C-terminal subunit (S2) (Dimitrov,
2004; Hofmann and Pohlmann, 2004). Recent studies also
suggested the presence of neutralizing domains in S2 (Duan
et al., 2005; Keng et al., 2005; Zeng et al., 2006; Zhang et al.,
33Y.-S. Yeung et al. / Virology 371 (2008) 32–432004). We have previously demonstrated that the SARS-CoV S
and S2, but not S1 nor other structural proteins, including
envelope (E), membrane (M) and nucleocapsid (N), can induce
apoptosis in Vero E6 cells (Chow et al., 2005). Other recent
studies showed that the E (Yang et al., 2005), M (Lai et al.,
2006; Zhao et al., 2006), N (Surjit et al., 2004; Zhao et al.,Fig. 1. Time course study of S2-induced apoptosis in Vero E6 cells. (a) Morphol
transductions from 0 to 96 h p.t. in 12- to 24-h intervals. Representative figures of thr
estimated quantitatively with Trypan blue exclusion assay. (c) The percentage of rAd
under fluorescence microscope after Hoechst 33342 staining. For both panels b and
mean (SEM). (d) Agarose gel electrophoresis showing the characteristic DNA ladderi
cells in four selected time points. Three micrograms of low molecular weight DNAw
arrowheads. The result is the representative of three independent experiments. ⁎pb02006), ORF 3a (Law et al., 2005), 3b (Yuan et al., 2005) and 7a
(Tan et al., 2004) could trigger apoptosis in different cell lines or
under specific culture conditions. As S is abundantly expressed
during the virus replication cycle, and that the silencing of S
expression exhibits an inhibition of cytopathic effect induced by
SARS-CoV infection (He et al., 2006), we sought to elucidateogy of Vero E6 cells under light microscope (40×) after rAd-Ctrl or rAd-S2
ee independent experiments are shown. (b) Cell viability along the time course is
-Ctrl or rAd-S2-transduced cells showing chromatin condensation was counted
c, average of three independent experiments is shown with standard error of the
ng pattern resulting from internucleosomal DNA cleavage in rAd-S2-transduced
as loaded into each well. The ladders with 200 bp increments are indicated with
.01 when compared with cells transduced by rAd-Ctrl under the same condition.
34 Y.-S. Yeung et al. / Virology 371 (2008) 32–43the molecular mechanisms of apoptosis mediated by S2 in Vero
E6 cells.
In depicting the biochemistry of SARS-CoV infections,
several microarray studies identified the differential expression
of genes related to apoptosis, cell cycle and stress response in
Vero (Leong et al., 2005), PBMC (Reghunathan et al., 2005; Yu
et al., 2005) and Huh-7 cells (Tang et al., 2005). Other in vitro
studies indicated that infection of SARS-CoV involves the
phosphorylation of p38 MAPK (Mizutani et al., 2004b), down-
regulation of Bcl-2 (Bordi et al., 2006; Ren et al., 2005), up-
regulation of Bax and activation of caspase 3 (Ren et al., 2005).
However, few efforts were put in trying to identify the role of
individual proteins of SARS-CoV in these biochemical path-
ways. In this regard, using an adenoviral system for gene de-
livery, we studied the changes of expression profiles in serially
sampled Vero E6 cells over-expressing S2 through microarray
technology. Based on our results, we proposed the alternations
of several physiological pathways that may be involved in S2-
induced apoptosis, including the activation of intrinsic apoptotic
pathway, inhibition of NFκB-downstream members and MAPK
cascade members. Moreover, a number of genes critically in-
volved in cell cycle control were also found to be differentially
regulated.
Results and discussion
Apoptosis induced by SARS-CoV S2 over-expression
To determine the appropriate time points for microarray
analysis, we first characterized the time-dependent induction of
apoptosis by S2 over-expression mediated by recombinant
adenoviruses (rAd). Starting from 24 h (h) post-transductions
(p.t.), cytopathic effects, including abnormal cell morphology
and shrinkage, were already observed in rAd-S2 but not rAd-
Ctrl-transduced Vero E6 cells (Fig. 1a). Results of cell viability
assay and chromatin condensation assay agreed well with theFig. 2. Functional classification of differentially expressed probe sets. Probe sets th
groups manually, with 9 groups of known functions and two groups representing hypo
with known functions showing up- and down-regulations is shown with empty and fil
while probe sets regulating cell cycle and proliferation are grouped into group 7.above observations (Figs. 1b and c). Cell viability of rAd-S2-
transduced cells dropped to the minimum at 96 h p.t. (Fig. 1b),
and the percentage of rAd-S2-transduced cells undergoing
apoptosis, as shown by chromatin condensation assay (Fig. 1c)
and internucleosomal DNA cleavage analysis (Fig. 1d), in-
creased rapidly and was peaked at 72 h p.t., which is the last
time-point of the assays. According to these apoptotic sig-
natures, which agree well with previous reports (Chow et al.,
2005; Jamshidi-Parsian et al., 2005), four time points at 12, 24,
48 and 72 h p.t., were chosen for the microarray analysis.
The global gene expression profile in Vero E6 cells
over-expressing SARS-CoV S2
A total of 1702 probe sets (3.2% of total probe sets) in the
array have exhibited a significant up- or down-regulation (at
least two-fold changes) in at least one of the time points upon
S2 over-expression. Only 33 of these differentially hybridized
probe sets showed both up- and down-regulation across the
four time points, while the rest of them showed either only up
(403 probe sets)- or down-regulated expression (1266 probe
sets) during the course of the experiment. Gene ontology study
classified 829 of the 1702 differential hybridized probe sets
into 9 groups with known functions (Fig. 2) according to a
defined classification (Tang et al., 2005). The relatively large
number of unclassified probe sets may be due to the less
characterized rhesus macaque genome, with unclassified probe
sets and hypothetical proteins contributed to 33.6% and 7.1%
of total probe sets respectively. Among the differentially
hybridized probe sets with known function, 68 and 82 probe
sets (representing 49 and 68 different genes, respectively), are
related to apoptosis and cell cycle/proliferation respectively.
The above data are summarized in Table 1. Changes of genes
expression related to other cellular pathways in S2 expressing
cells can be found in our Web page (http://evolution.hku.hk/
publications/SARS_microarray.htm).at were differentially expressed by more than two-folds were classified into 11
thetical/miscellaneous proteins and unknown proteins. The number of probe sets
led bars respectively. The first group represents the probe sets related to apoptosis
Table 1
Signal log ratios (log2 scale) on the fold change of gene expression in S2-expressing Vero E6 cells (only genes highly related to apoptosis and cell cycle and
proliferation are shown)
Categories and
subcategories
Probe set ID Gene symbol Description Log 2 ratio (sample/control) a
(h p.i.)
12 24 48 72
Apoptosis
Anti-apoptosis
MmugDNA.28580.1.S1_at ANXA4 Annexin A4 −0.39 −0.28 −0.45 −1.01
MmugDNA.34272.1.S1_s_at API5 Apoptosis inhibitor 5 −1.44 −0.29 −0.36 −1.08
MmugDNA.29603.1.S1_at BCL2 B-cell CLL/lymphoma 2 0.40 −0.49 −1.24 −1.78
MmugDNA.12133.1.S1_at BCLXL BCL2-like 1 (BCL2L1) −1.56 −0.23 −0.77 −1.92
MmugDNA.1928.1.S1_at CTNNA1 Catenin (cadherin-associated protein),
alpha 1, 102 kDa
−0.50 −0.08 −0.62 −1.22
MmugDNA.39222.1.S1_at CFL1 Cofilin 1 (non-muscle) −1.11 −0.12 −0.53 −1.44
MmugDNA.35450.1.S1_at CSTB Cystatin B (stefin B) −1.03 −0.97 −0.85 0.01
MmugDNA.21273.1.S1_at HSPA5 Heat shock 70 kDa protein 5
(glucose-regulated protein, 78 kDa)
0.15 0.39 1.88 2.15
MmugDNA.725.1.S1_at HIPK3 Homeodomain interacting protein kinase 3 −2.13 −0.17 −0.17 −1.82
MmugDNA.29385.1.S1_at MIRN21 MicroRNA 21 −0.65 −0.22 −0.79 −1.12
MmugDNA.38922.1.S1_at MCL1 Myeloid cell leukemia sequence 1 (BCL2-related) −0.95 −0.07 −0.48 −1.09
MmugDNA.11909.1.S1_s_at ARHGDIA Rho GDP dissociation inhibitor (GDI) alpha −1.35 −0.17 −1.17 −1.01
MmugDNA.34988.1.S1_at TXNDC Thioredoxin domain containing −1.40 0.02 −0.05 −1.11
MmugDNA.40138.1.S1_at TNFAIP3 Tumor necrosis factor, alpha-induced protein 3 0.57 0.45 0.72 1.19
MmugDNA.32694.1.S1_at TNFAIP8 Tumor necrosis factor, alpha-induced protein 8 −0.18 −0.69 −0.95 −1.46
MmugDNA.30167.1.S1_at TRA1 Tumor rejection antigen (gp96) 1 −0.24 0.42 1.41 0.93
MmugDNA.6621.1.S1_at TRA1 Tumor rejection antigen (gp96) 1 0.16 0.42 1.41 1.14
MmugDNA.3345.1.S1_at VEGF Vascular endothelial growth factor −0.94 −0.48 −0.05 −1.05
Pro-apoptosis
MmugDNA.6382.1.S1_at BIRC3 Baculoviral IAP repeat-containing 3 −0.33 −0.37 −0.40 −1.05
MmugDNA.30317.1.S1_at BIRC4 Baculoviral IAP repeat-containing 4 1.47 0.28 0.53 1.22
MmugDNA.2328.1.S1_at BAG2 BCL2-associated athanogene 2 1.12 0.10 −0.12 0.65
MmugDNA.4144.1.S1_s_at BCL2L11 BCL2-like 11 (apoptosis facilitator) −1.61 −0.49 −0.40 −0.85
MmugDNA.23713.1.S1_at BOMB BH3-only member B protein −0.99 −0.28 −0.57 −1.23
MmugDNA.41236.1.S1_at CASP2 Caspase 2, apoptosis-related cysteine peptidase
(neural precursor cell expressed,
developmentally down-regulated 2)
−0.72 0.35 −0.21 −1.40
MmugDNA.13586.1.S1_at CASP8 Caspase 8, apoptosis-related cysteine peptidase −1.49 −0.45 −0.62 −1.38
MmugDNA.15712.1.S1_x_at CTSB Cathepsin B 0.13 0.02 −0.07 1.08
MmugDNA.19990.1.S1_s_at CD99 CD99 antigen −1.08 −0.24 −0.25 −1.28
MmugDNA.15069.1.S1_at CYCS Cytochrome c, somatic 1.50 0.58 0.40 1.63
MmugDNA.39077.1.S1_at DAPK3 Death-associated protein kinase 3 −1.19 −0.68 −0.47 −0.37
MmugDNA.29093.1.S1_at DOC1 Down-regulated in ovarian cancer 1 −0.13 −0.31 −0.79 −1.53
MmugDNA.24700.1.S1_at ESRRBL1 Estrogen-related receptor beta like 1 −1.25 −0.32 −0.67 −1.51
MmugDNA.7450.1.S1_at FAF1 Fas (TNFRSF6) associated factor 1 −0.40 −0.60 −0.48 −1.08
MmugDNA.34508.1.S1_at HIP1 Huntingtin interacting protein 1 1.10 −0.02 0.11 0.47
MmugDNA.38424.1.S1_at IHPK2 Inositol hexaphosphate kinase 2 −0.23 −0.50 −0.60 −1.18
MmugDNA.22620.1.S1_at LGALS7 Lectin, galactoside-binding, soluble, 7 (galectin 7) −0.10 −0.19 −0.53 −1.20
MmugDNA.21644.1.S1_at MAPK1 Mitogen-activated protein kinase 1 −1.41 −0.32 −0.27 −1.42
MmugDNA.834.1.S1_at RPL4 Mitogen-activated protein kinase kinase kinase 13 −1.75 −0.46 −0.41 −1.44
MmugDNA.19461.1.S1_at WIG1 p53 target zinc finger protein −1.76 −0.73 −0.70 −1.94
MmugDNA.22348.1.S1_at PSEN1 Presenilin 1 (Alzheimer disease 3) −1.00 −0.33 0.12 −0.61
MmugDNA.5589.1.S1_at PURB Purine-rich element binding protein B −0.90 −0.94 −1.14 −1.09
MmugDNA.21841.1.S1_s_at RHOB Ras homolog gene family, member B −1.44 −0.63 −0.86 −1.23
MmugDNA.25692.1.S1_at STK3 Serine/threonine kinase 3 (STE20 homolog, yeast) −0.90 −0.15 −0.35 −1.02
MmugDNA.39549.1.S1_at STK4 Serine/threonine kinase 4 −1.89 −0.40 −0.61 −1.29
MmugDNA.7204.1.S1_at SGK Serum/glucocorticoid regulated kinase 0.20 0.38 0.88 1.38
MmugDNA.40778.1.S1_at SH3MD2 SH3 multiple domains 2 1.00 −0.01 0.12 0.16
MmugDNA.37821.1.S1_at TNFRSF19 Tumor necrosis factor receptor superfamily, member 19 −1.47 −0.97 −0.84 −2.01
MmugDNA.39342.1.S1_s_at TNFRSF21 Tumor necrosis factor receptor superfamily, member 21 −0.42 −0.26 −0.74 −1.17
MmugDNA.34645.1.S1_s_at ZFP36L1 Zinc finger protein 36, C3H type-like 1 −0.16 −0.41 −0.73 −1.05
DNA repair
MmugDNA.12810.1.S1_at BRCA2 Breast cancer 2, early onset −1.18 −0.52 0.26 −0.17
Cell cycle and proliferation
MmugDNA.880.1.S1_at ADAMTS1 ADAM metallopeptidase with
thrombospondin type 1 motif, 1
−0.04 −0.32 −1.36 −2.22
(continued on next page)
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Table 1 (continued)
Categories and
subcategories
Probe set ID Gene symbol Description Log 2 ratio (sample/control) a
(h p.i.)
12 24 48 72
Apoptosis
MmugDNA.18873.1.S1_at APBB2 Amyloid beta (A4) precursor protein-binding,
family B, member 2 (Fe65-like)
−0.85 −0.33 −0.54 −1.02
MmugDNA.40593.1.S1_at ANAPC5 Anaphase promoting complex subunit 5 −1.21 −0.18 −0.36 −1.03
MmugDNA.25197.1.S1_at ASPM Asp (abnormal spindle)-like, microcephaly
associated (Drosophila)
1.14 −0.23 −0.16 0.64
MmugDNA.27494.1.S1_at BTBD7 BTB (POZ) domain containing 7 −1.60 −0.32 −0.77 −1.95
MmugDNA.40767.1.S1_at BUB3 BUB3 budding uninhibited by
benzimidazoles 3 homolog (yeast)
−1.02 −0.24 −0.41 −0.94
MmugDNA.24430.1.S1_at CDC25A Cell division cycle 25A 0.46 0.83 1.08 1.55
MmugDNA.8073.1.S1_at CDC25C Cell division cycle 25C −1.00 −0.86 −0.46 −1.49
MmugDNA.7114.1.S1_at CDCA2 Cell division cycle associated 2 −0.54 −0.83 −1.44 −0.18
MmugDNA.15060.1.S1_at CEP1 Centrosomal protein 1 1.01 −0.02 −0.21 0.54
MmugDNA.27098.1.S1_at CCND1 Cyclin D1 1.04 0.56 0.20 0.76
MmugDNA.8564.1.S1_at CCNE2 Cyclin E2 −1.34 0.22 0.25 −0.82
MmugDNA.38294.1.S1_at CCNG2 Cyclin G2 −1.56 −0.63 0.01 −2.04
MmugDNA.14485.1.S1_at CDK6 Cyclin-dependent kinase 6 −1.23 −0.66 −0.91 −1.46
MmugDNA.12064.1.S1_at CDKN2B Cyclin-dependent kinase inhibitor
2B (p15, inhibits CDK4)
−1.13 −0.30 −0.04 −1.12
MmugDNA.31081.1.S1_at DAZAP2 DAZ associated protein 2 −1.27 −0.55 −1.06 −1.85
MmugDNA.15195.1.S1_at DBC1 Deleted in bladder cancer 1 0.06 −0.35 −1.26 −0.91
MmugDNA.36289.1.S1_s_at DLEU2 /// BCMSUNL Deleted in lymphocytic leukemia,
2 /// BCMS upstream neighbor-like
0.32 0.45 0.74 1.31
MmugDNA.16818.1.S1_at DAB2 Disabled homolog 2, mitogen-responsive
phosphoprotein (Drosophila)
−0.11 −0.14 −0.23 −1.01
MmugDNA.32685.1.S1_at DDR2 Discoidin domain receptor family, member 2 0.66 0.17 0.36 1.52
MmugDNA.28062.1.S1_s_at DLG1 Discs, large homolog 1 (Drosophila) −0.14 −0.48 −0.39 −1.08
MmugDNA.32495.1.S1_at DDIT3 DNA-damage-inducible transcript 3 0.11 1.30 0.87 1.32
MmugDNA.24043.1.S1_at DUSP1 Dual specificity phosphatase 1 −1.04 −0.10 0.30 −0.04
MmugDNA.23886.1.S1_at DNCH1 Dynein, cytoplasmic, heavy polypeptide 1 0.66 0.73 0.35 1.12
MmugDNA.13015.1.S1_at EML4 Echinoderm microtubule associated protein like 4 1.25 0.32 0.32 1.20
MmugDNA.38400.1.S1_at ENTH Enthoprotin −1.06 −0.36 −0.37 −1.10
MmugDNA.31099.1.S1_s_at EPLIN Epithelial protein lost in neoplasm beta −0.78 −0.75 −1.34 −1.40
MmugDNA.35735.1.S1_at EPB41L4A Erythrocyte membrane protein band 4.1 like 4A −0.68 −0.41 −0.75 −1.43
MmugDNA.29681.1.S1_at FBXO45 F-box protein 45 0.91 0.26 0.40 1.07
MmugDNA.25606.1.S1_s_at FUS Fusion (involved in t(12;16) in malignant liposarcoma) −2.62 −0.90 −1.42 −1.31
MmugDNA.7304.1.S1_s_at GSPT1 G1 to S phase transition 1 −0.37 −0.31 −0.87 −1.50e
MmugDNA.33793.1.S1_at GTSE1 G-2 and S-phase expressed 1 1.01 −0.45 −0.19 0.08
MmugDNA.33680.1.S1_at GSN Gelsolin (amyloidosis, Finnish type) −1.14 0.00 −0.16 −0.89
MmugDNA.38529.1.S1_at ENPEP Glutamyl aminopeptidase (aminopeptidase A) −0.60 −0.43 −0.25 −1.08
MmugDNA.25216.1.S1_at GPC4 Glypican 4 −0.43 −0.59 −1.08 −1.42
MmugDNA.41267.1.S1_at GAS1 Growth arrest-specific 1 −0.16 0.13 −0.27 −1.40
MmugDNA.23210.1.S1_x_at IGF2 Insulin-like growth factor 2 (somatomedin A) 0.32 0.14 −0.89 −1.02
MmugDNA.2176.1.S1_at ISG20 Interferon stimulated exonuclease gene 20 kDa 0.09 0.19 0.43 1.07
MmugDNA.18344.1.S1_at JAG1 Jagged 1 (Alagille syndrome) −0.10 −0.82 −1.04 −1.07
MmugDNA.30627.1.S1_at JUB Jub, ajuba homolog (Xenopus laevis) −0.68 −0.06 −0.27 −1.09
MmugDNA.21869.1.S1_at KIF22 Kinesin family member 22 −1.13 −0.37 −0.31 −1.16
MmugDNA.17868.1.S1_at MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) −1.17 −0.40 −0.22 −0.89
MmugDNA.11043.1.S1_s_at MAP7 Microtubule-associated protein 7 −0.34 −0.59 −0.58 −1.19
MmugDNA.38080.1.S1_at MPHOSPH9 M-phase phosphoprotein 9 −0.87 −0.77 −0.61 −1.50
MmugDNA.40010.1.S1_at NF2 Neurofibromin 2 (bilateral acoustic neuroma) −0.40 0.02 −0.08 −1.13
MmugDNA.11581.1.S1_at NEK9 NIMA (never in mitosis gene a)-related kinase 9 −1.36 −0.42 −0.71 −1.71
MmugDNA.25696.1.S1_at NEK2 NIMA (never in mitosis gene a)-related kinase 2 −1.53 −0.80 −0.44 −1.37
MmugDNA.15458.1.S1_at NOTCH2 Notch homolog 2 (Drosophila) −0.96 −0.30 −0.40 −1.14
MmugDNA.31795.1.S1_at NUCKS1 Nuclear casein kinase and
cyclin-dependent kinase substrate 1
−1.19 −0.82 −1.07 −0.43
MmugDNA.18184.1.S1_at PAK3 P21 (CDKN1A)-activated kinase 3 1.40 0.09 0.17 1.52
MmugDNA.6179.1.S1_at PARD6B Par-6 partitioning defective 6 homolog
beta (C. elegans)
−1.09 −0.32 −0.55 −0.95
MmugDNA.28892.1.S1_at PPIG Peptidylprolyl isomerase G (cyclophilin G) 1.14 0.00 −0.02 0.51
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Cell cycle and proliferation
MmugDNA.30055.1.S1_at PAFAH1B1 Platelet-activating factor acetylhydrolase,
isoform Ib, alpha subunit 45 kDa
−1.03 −0.40 −0.51 −1.19
MmugDNA.27441.1.S1_at PPP2R1B Protein phosphatase 2 (formerly 2A),
regulatory subunit A (PR 65), beta isoform
−1.02 −0.37 −0.47 −0.79
MmugDNA.3729.1.S1_at RIF1 RAP1 interacting factor homolog (yeast) −1.76 −0.49 −0.70 −1.64
MmugDNA.23090.1.S1_at RERG RAS-like, estrogen-regulated, growth inhibitor −0.67 −0.43 −1.40 −2.26
MmugDNA.24655.1.S1_s_at RBBP6 Retinoblastoma binding protein 6 0.77 0.33 0.27 1.01
MmugDNA.1893.1.S1_at RNGTT RNA guanylyltransferase and 5′-phosphatase −1.06 −0.50 −0.51 −1.27
MmugDNA.43216.1.S1_at S100A6 S100 calcium binding protein A6 (calcyclin) −0.20 −0.25 −0.30 −1.15
MmugDNA.18017.1.S1_at SEP2 Septin 2 −2.05 −0.63 −0.90 −2.10
MmugDNA.7350.1.S1_s_at SSR1 Signal sequence receptor, alpha
(translocon-associated protein alpha)
−1.12 −0.04 0.23 −0.20
MmugDNA.29506.1.S1_at SMC5L1 SMC5 structural maintenance of
chromosomes 5-like 1 (yeast)
0.81 0.27 0.06 1.17
MmugDNA.10117.1.S1_s_at SKP2 S-phase kinase-associated protein 2 (p45) −1.68 −0.61 −0.65 −1.02
MmugDNA.23385.1.S1_at TSPAN2 Tetraspanin 2 −0.57 −0.51 −0.70 −1.07
MmugDNA.39770.1.S1_at TSPAN31 Tetraspanin 31 −0.80 −0.40 −0.24 −1.19
MmugDNA.20960.1.S1_at TGFA Transforming growth factor, alpha −1.50 −0.17 −0.44 −1.39
MmugDNA.35789.1.S1_at TUSC2 Tumor suppressor candidate 2 −0.71 −0.11 −0.22 −1.03
MmugDNA.40025.1.S1_at UHMK1 U2AF homology motif (UHM) kinase 1 −1.38 −0.36 −0.60 −1.80
a The bolded numbers represent genes with more than two-fold up-regulation, while the italicized numbers represent genes with more than two-fold down-regulation.
Table 2
Comparison of the gene expression levels in S2-expressing Vero E6 cells
analyzed with microarray and real-time PCR
Gene
name
Microarray a Real time b
12 24 48 72 12 24 48 72
ATF1 −1.47 −0.47 −0.50 −1.24 −1.13 −0.15 −0.10 −1.63
Bcl−xL −1.56 −0.23 −0.77 −1.92 −0.87 −0.58 −0.22 −1.73
CDK6 −1.23 −0.66 −0.91 −1.46 −0.50 −0.08 −1.00 −1.98
CYCS 1.50 0.58 0.40 1.63 1.03 0.62 0.45 1.02
GRP78 0.15 0.39 1.88 2.15 −0.26 0.67 1.44 1.84
GRP94 0.16 0.42 1.41 1.15 0.41 0.23 0.96 1.21
IGF2 0.32 0.14 −0.89 −1.02 0.65 0.58 −1.83 −2.28
IkBkB −1.10 −0.56 −0.58 −0.76 −1.02 0.32 −0.13 −0.55
JunD −0.27 0.01 0.22 −1.00 −0.85 −0.32 0.17 −1.12
MAPK1 −1.41 −0.32 −0.27 −1.42 −1.22 −0.83 0.52 −2.80
For both assays, bolded numbers represent genes with more than two-fold up-
regulation, while italicizec numbers represent genes with more than two-fold
down-regulation.
a For each gene, only the probe set with the largest variation is shown.
b The average expression level of triplicate experiments is shown.
Table 1 (continued)
Categories and
subcategories
Probe set ID Gene
symbol
Description Log 2 ratio (sample/control) a
(h p.i.)
12 24 48 72
Apoptosis
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To verify the result of the microarray analysis, relative expres-
sion levels of selected genes were assayed with real-time quan-
titative PCR. The relative quantification by real-time PCR
suggested the creditability of the array analysis (Table 2). It is
noted that the scale of expression level detected by these two
systems may vary, possibly due to the variation of probing re-
gions, sensitivity of assays, as well as the saturation of fluores-
cence signals in array analysis.
Transcriptional inactivation of extrinsic apoptotic pathway
Apoptosis is initiated through two interrelated pathways, one
involving the engagement of TNF family of death receptors,
namely the extrinsic pathway, and the other involving Bax-
mediated release of cytochrome c (CYCS) from mitochondria,
namely the intrinsic pathway. In the extrinsic pathway, engage-
ment of death receptors have been shown to trigger the activa-
tion of MAPK/JNK, caspase 8 and caspase 3, which leads to
apoptosis (Baetu and Hiscott, 2002). Based on our microarray
data, expression of a number of genes involved in the extrinsic
pathways of apoptosis was down-regulated. TRAIL, which is a
ligand of death receptor 4/5 and a potent apoptotic inducer, and
FAF1, which binds to FAS antigen and initiates apoptosis, were
both found to be down-regulated upon S2 over-expression.
These observations suggest a possible suppression of TRAIL-
induced and FasL-induced apoptotic pathways. A downstream
target of these two pathways, caspase 8, was also down-
regulated at 48 and 72 h p.t. Although the down-regulation of
HIPK3, a gene that activates the Fas apoptotic pathway (Curtin
and Cotter, 2004), was observed, the possibility that the effect ofHIPK3 as a feedback mechanism cannot be excluded. Inhibition
of apoptosis is a common strategy employed by viruses to evade
host defense mechanism that limits viral replication by
triggering the apoptosis of the infected cells (Hiscott et al.,
2001). From this, the blockage of extrinsic apoptotic pathway
by S2 may represent a viral defense mechanism to avoid pre-
mature cell death before the completion of viral replication.
Transcriptional activation of intrinsic apoptotic pathway
In our study, several lines of evidence suggest the triggering
of intrinsic apoptotic pathway in response to S2 expression.
From the microarray data, the expression of Mdm2, a protein
Fig. 3. Bcl-xL blocks S2-induced apoptosis in Vero E6 cells. Different dosage of
rAd-Bcl-xL was co-infected with 50 MOI of rAd-S, -S1, -S2 or rAd-Ctrl and the
effect on cell death and apoptosis induced by the rAds were assayed through
(a) Trypan blue exclusion assay and (b) Hoechst 33342 staining at day 5 and day
3 p.t. respectively. Both figures indicated the average of three independent
experiments with SEM.
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protein p53 (Momand et al., 1992), was showed to be down-
regulated. The down-regulation of Mdm2 thus suggests the
possible increase of the activity of a pro-apoptotic Bcl-2 family
member, Bax, via p53 (Miyashita and Reed, 1995). Bax
accelerates the opening of the mitochondrial porin channel and
mediates the release of CYCS (Narita et al., 1998). Indeed, as
indicated in our data, the expression of S2 did up-regulate the
transcription of CYCS, the leakage of CYCS is thus expected to
be increased, which enables the formation of apoptosome and
the subsequent activation of the downstream effector caspase
cascade, and ultimately leads to apoptosis (Cain et al., 2002).
Collectively, these data suggest that the intrinsic apoptotic
pathway may possibly be responsible for the S2-induced apo-
ptosis in Vero E6 cells.
In SARS-CoV-infected cells, down-regulation of Bcl-2 and
up-regulation of Bax has been reported (Ren et al., 2005). These,
together with the capacity of Bcl-2 to overcome the apoptotic
effects of SARS-CoV (Bordi et al., 2006), imply the involve-
ment of the intrinsic apoptotic pathway. In our array data, despite
the fact that a pro-apoptotic member of the Bcl-2 family, Bim
(Marani et al., 2002), was down-regulated, a number of anti-
apoptotic Bcl-2 family members, including Mcl-1, Bcl-xL and
Bcl-2 (Gross et al., 1999; Reed, 1996), were also found to be
down-regulated. These anti-apoptotic members are known to
inhibit the release of CYCS from mitochondria to cytosol by
blocking the mitochondrial porin channel (Shimizu et al., 1999).
To further elucidate the possible inhibitory role of the anti-
apoptotic Bcl-2 protein members in S2-induced apoptosis, we
over-expressed Bcl-xL in Vero E6 cells through rAd transduc-
tion. As shown in Fig. 3, over-expression of Bcl-xL significantly
reduced the extent of apoptosis in Vero E6 cells induced by both
S2 and S. In contrast, co-transduction of rAd-Ctrl with rAd-S2 or
rAd-S has no significant effect on the level of apoptosis mediated
by S nor S2 (data not shown). Besides the important role of Bcl-
xL in mitochondrial apoptosis, it is noted that over-expression of
Bcl-xL may inhibit other mitochondria-independent apoptotic
pathways like phosphorylation of JNK (Srivastava et al., 1999).
Induction of endoplasmic reticulum stress responses
The expression of full length spike protein has been dem-
onstrated to induce specific ER stress and unfolded protein
response (UPR) while other viral proteins like M, N and E do not
(Chan et al., 2006). Previous reports showed that ER stress may
trigger 3 branches of UPR including activating transcription
factor 6 (ATF6), inositol-requiring enzyme 1 (IRE1) and PKR-
like ER kinase (PERK)-related signaling pathways (Schroder and
Kaufman, 2005). Chan et al. (2006) demonstrated the ER stress
induced by spike protein does not trigger ATF6 and IRE1-related
signaling pathways while GRP78 and GRP94, indicators for
activation of PERK-related signaling pathways (Schroder and
Kaufman, 2005), are up-regulated. Interestingly, our array data on
the expression of these genes, as well as the real-time PCR
analysis of GRP78 and GRP94 expression (Table 2), are con-
sistent with these findings, suggesting a possible role of the S2
subunit in the specific ER stress induced by S. Although GRP78/94-inducedUPR takes part in alleviating ER stress and promoting
anti-apoptotic signaling (Ma and Hendershot, 2004), a prolonged
ER stress may induce mitochondrial apoptosis by releasing
calcium ion and down-regulating Bcl-2 (Breckenridge et al.,
2003). Coincidentally, Bcl-2 was found to be down-regulated in
this study (Table 1). ER stress may also activate caspase 4, which
is a homologue to murine caspase 12 (Hitomi et al., 2004), to
induce mitochondria-independent apoptotic response. However,
due to the fact that murine caspase 12 is triggered through IRE1
activation (Yoneda et al., 2001) and that the over-expression of
spike protein does not activate IRE1 (Chan et al., 2006), it is
anticipated that caspase 4 may not be activated by SARS-CoV
spike protein. Taken together, since a similar transcriptional
response was observed by the expression of S of both SARS-CoV
andMHV but not other viral proteins (Chan et al., 2006; Versteeg
et al., 2007), we proposed that the potential ER stress observed in
our assay is specific to S2 expression.
Inactivation of the NFκB pathway
The transcription factor NFκB is a key regulator in cell
proliferation, protecting cells from apoptosis under most cir-
cumstances and accelerating apoptosis in the others (Piva et al.,
Fig. 4. S2-mediated inhibition of cell proliferation in Vero E6 cells. Vero E6 cells
were transduced with the indicated rAds and their proliferations were estimated
withMTTcell proliferation assay and are expressed as percentage of proliferation
of mock-infected cells. Time- and dose-dependent anti-proliferation effect of S2
was shown in panels a and b, respectively. The time-dependent effect was
performed with rAd of 25 MOI and cells in the dose-dependent experiment were
collected at 3 days p.t. Results shown are the average of three independent
experiments with SEM. ⁎pb0.01 when compared with cells transduced by rAd-
Ctrl under the same condition.
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as supported by the regulation of several targets and regulators of
NFκB. In particular, IκBκB, which is responsible for the acti-
vation of NFκB (Scheidereit, 2006), was down-regulated at the
early time-point upon S2 expression. In addition, at both early
(12 h p.t.) and late (72 h p.t.) time points, a negative regulator
of NFκB, the TNFAIP3 (Wertz et al., 2004), was up-regulated,
while positive regulators, including ECT2, FKBP1A, TRAIL,
TMEM9B and TRIM38 (Matsuda et al., 2003), were down-
regulated. NFκB-dependent decrease of the expression level
of anti-apoptotic factors like Bcl-2 (Catz and Johnson, 2001),
Bcl-xL (Chen et al., 2000), Mcl-1 (Henson et al., 2003), A1/Bfl-1
and TRAF-1 (Akari et al., 2001) has been demonstrated.
Down-regulation of the MAPK pathway
The MAPK-dependent signaling cascade is known to be
important for regulating apoptosis, cell differentiation and
proliferation. Potential suppression of the MAPK pathways is
suggested to be mediated by the down-regulation of its key
members, p38 MAPK (MAPK1) and p38 MAPKα (MAPK14),
and the key targets, including ATF1 (Tan et al., 1996), CREB1
(Tan et al., 1996), JunD (Stocco et al., 2002) and Sp1 (Moon
et al., 2006). While their transcriptional profiles have not been
investigated in SARS-CoV-infected cells, based on our
microarray results, we anticipate a conceivable role of S2 in
down-regulating these genes at the transcription level. Sup-
pression of MAPK cascade by S2 may imply various
downstream responses as suggested by its overall regulation
observed in other cell types. Consequential down-regulations of
ATF1, CREB1, JunD and Sp1 observed in S2-expressing Vero
E6 cells suggested the trend towards cell death. It is noted that
the p38 MAPK, CREB, MSK-1, ERK1/2 and ATF1 (Mizutani
et al., 2004b), and PI3k/Akt-dependent pathways (Mizutani et
al., 2004a) were activated in SARS-CoV-infected Vero E6 cells,
although their role in S2-mediated apoptosis has not yet been
defined. Indeed, the activation of these proteins may possibly
due to the presence of other viral proteins or the double-stranded
RNA intermediates of SARS-CoV through different machiner-
ies (Mizutani et al., 2004b).
Transcriptional regulation of genes involved in cell
cycle control
Cell cycle progression is mainly governed by proteins in-
cluding cyclins, cyclin-dependent kinase (CDK) and CDK
inhibitors, which cooperatively control the phosphorylation of
retinoblastoma (Rb) (Sherr, 1996). The cyclin E2 (CCN E2)/
CDK6 complex is important for the progression of cell cycle in
the G1/S phase. While IGF2 acts upstream of the complex
(Zhang et al., 1999), the activity of CTNN B1 is regulated by
the complex through binding (Park et al., 2004). MDM2 is a
negative regulator of p53 and it has been demonstrated to inhibit
the G1 arrest (Chen et al., 1996). The reduced MDM2 expres-
sion was expected to activate the inhibitor of CDKN 1A (p21,
Cip1) via p53 (Waldman et al., 1995). In this study, tran-
scriptional regulations of a number of cyclins, CDKs and theirinhibitors were detected. Cyclin D1 (CCN D1) was found to be
up-regulated, while the expressions of IGF2, CCN E2, CDK6
and CTNN B1 were all suppressed upon S2 over-expression.
CDKN 2B, a CDK inhibitor involved in negative regulation of
cell proliferation, was also found to be down-regulated (Table 1).
Thus, our data suggest the possibility of cell cycle arrest in G1/S
phase by S2 through modulating G1 controlling cyclins. While
the regulation of cell cycle mediators leading to cell proliferation
inhibition is a common phenomenon in virus infection cycle, we
observed, as described above, an inhibition of cell proliferation
in cells transduced with rAd-S2 (Fig. 4). Further study to
confirm the S2-induced arrest at G1/S phase will be indicative to
understand the role of S2 in the pathogenesis of SARS-CoV.
It has been shown that SARS-CoV can induce cell pro-
liferation arrest (Mizutani et al., 2006). Recent studies sug-
gested the induction of G0/G1 phase arrest by SARS-CoV
ORF 3b and 7a (Yuan et al., 2005; Yuan et al., 2006) and S
phase arrest by N protein (Surjit et al., 2006). While the phase in
which cell cycle is arrested in SARS-CoV-infected cells re-
mained to be determined, the inhibition of G1 phase progression
in mouse hepatitis virus (MHV) p28 protein-transduced (Chen
et al., 2004) and in IBV-infected (Dove et al., 2006) cells with
increase viral protein productions suggested the possible role
of potential G1 arrest in rAd-S2-transduced cells. This in turn
Table 3
List of primers for quantitative real-time PCR analysis
Primer name Primer sequence (5′-3′) Product size
1 β-Actin_F ATCGTGCGTGACATTAAGGAG 179
β-Actin_R AGGAAGGAAGGCTGGAAGAG
2 ATF1_F CAGGCACAGATGGAGTACAG 131
ATF1_R CTGATTGCTGGGCACAAGTA
3 Bcl-xL_F TTGAACAGGTAGTGAATGAACTC 139
Bcl-xL_R AAGCTGCGATCCGACTCACC
4 CDK6_F CCGAAGTCTTGCTCCAGTC 124
CDK6_R CCTAGTTGATCGACATCTGAA
5 CYCS_F TCCACATGGCTGTCAAGAA 113
CYCS_R CACGACGCCCAGTTATCTA
6 GRP78_F GGCAACTGGCTGAAAGGT 92
GRP78_R GGCAGTGCAGCAGAGGTC
7 GRP94_F CGCTTCGGTCAGGATATC 151
GRP94_R CTGTCGTGTCTTCTGTTGTCT
8 IGF2_F GTCCAGCAATCGGAAGTGA 125
IGF2_R GGAAGTGGAACCGAGAGATT
9 IkBkB_F GCAGCAAGGAGAACAGAGG 152
IkBkB_R CGACGGTCACTGTGTACTTCT
10 JunD_F CCTCAAGAGTCAGAACACGGA 98
JunD_R CGCTGTTGACGTGGCTGA
11 MAPK1_F CATCGCCGAAGCACCATT 108
MAPK1_R CTGTATCCTGGCTGGAATCT
40 Y.-S. Yeung et al. / Virology 371 (2008) 32–43plays a role in the lytic replication cycle, driving the infected
cells to apoptosis showing cytopathic effect.
Overall conclusive remarks
In this study, we investigated the possible modulation of the
host cellular factors by S2 of SARS-CoV,whichmay be important
inmediating cell death and cell proliferation arrest.We observed a
suppression of extrinsic apoptotic pathway and an activation of
intrinsic pathway. Together with the down-regulation of genes
involved in the MAPK and NFκB signaling pathway, these
changes are believed to be responsible for the S2-induced
apoptotic cell death. Modulation of expression of G1 cyclins also
suggests the capacity of inducingG1 cell cycle arrest by S2. These
data collectively elucidate the possible role of S2 in disease
pathogenesis and viral replication. In summary, our investigation
unraveled the candidate physiological pathways involved in S2-
induced apoptosis at a molecular level, providing a foundation for
researchers to design experiments based on testable hypothesis
targeting individual genes. This information is expected to shed
light on the molecular mechanisms of the pathogenesis of SARS,
which is important for the development of antiviral therapy.
Materials and methods
Cell cultures
HEK293-derived AD-293 cells (Stratagene) used to propa-
gate recombinant adenoviruses (rAds), and the African green
monkey kidney cell line Vero E6 cells (CRL-1586, American
Type Culture Collection) used for adenoviral transduction and
microarray analysis were cultured and maintained as described
(Chow et al., 2005).
Preparation of recombinant adenoviruses and transduction of
Vero E6 cells
Recombinant adenoviruses expressing S (rAd-S), S1 (rAd-
S1) and S2 (rAd-S2), as well as a control rAd with no transgene
(rAd-Ctrl), were constructed, propagated, purified and titrated as
previously described (Chow et al., 2005). For all adenoviral
transductions in this study, monolayer of Vero E6 cells was
infected with minimal volume of purified rAds at a multiplicity
of infections (MOI) of 100 unless otherwise specified. At 2 h p.t.,
minimum essential medium with eagle's salts (EMEM; Gibco-
BRL) was added to the transduced cells at a final concentration
of 1% heat-inactivated fetal bovine serum (FBS; Gibco-BRL)
and 1% antibiotics–antimycotic (Gibco-BRL).
Assessment of apoptosis induced by S2 expression
Cell viability, nuclear morphology and the extent of DNA
fragmentation of rAd-S2 and rAd-Ctrl-transduced Vero E6 cells
were investigated at the indicated time intervals using Trypan blue
exclusion assay, Hoechst 33342 staining (Sigma) and genomic
DNA laddering assay, respectively. All three assays were
performed in triplicate as previously described (Chow et al., 2005).RNA sample preparation and microarray analysis
To identify the differentially expressed transcripts induced by
S2 expression, the global gene expression profiles of rAd-Ctrl
and rAd-S2-transduced Vero E6 cells at 12, 24, 48 and 72 h p.t.
were compared using GeneChip® Rhesus Macaque Genome
Array (Affymetrix). The microarray was spotted with 52,865
probe sets referring to more than 47,000 Macaca mulatta
transcripts. For both rAd-Ctrl and rAd-S2-transduced cells, total
RNAwere extracted from approximately 5×106 cells at each of
the 4 indicated time points using RNeasy Mini Kit (Qiagen)
according to manufacturer's instructions. The integrity of the
extracted RNA was confirmed by electrophoresis in a 1%
denaturing agarose gel and the aliquots were stored at −80 °C
until further use. Fifteen micrograms of the extracted RNA from
each sample at each of the time points was used in microarray
analysis. Standard sample preparation using the one cycle target
labeling system, slide hybridization and scanningwas performed
in the Institute of Systems Biology (ISB; Seattle, USA) accord-
ing to manufacturer's instructions. The intensity value was then
processed with RMAExpress for background adjustment,
quartile normalization and summarization with the Web-based
SEBAMS system. The physiological functions of the transcripts
were annotated according to the original annotation of the array,
iHOP database (Robert Hoffmann) and NetAffy database
(Affymetrix).
Real-time quantitative PCR
Real-time quantitative PCR analysis was performed to validate
the transcript expression pattern detected in the microarray for
selected transcripts (n=6) using specific primers (Table 3). First
strand cDNAwas synthesized from 2 μg of the extracted RNA at
each of the time point using MMLV-reverse transcriptase
41Y.-S. Yeung et al. / Virology 371 (2008) 32–43(Promega) according to manufacturer's instructions. Real-time
PCR analysis was then performed with the EvaGreen real-time
PCR system (Biotium Inc.) and the iCycler real-time PCR
machine (Bio-Rad) according to the manufacturers' instructions.
The amplification cycle included initial denaturation at 94 °C
10min and 45 cycles of (94 °C 10 s, 55 °C 10 s, 72 °C 10 s, 80 °C
7 s), followed by 76 cycles of (+0.5 °C per s) from 56 °C for
melting curve analysis. Amplification of the specific genes was
repeated in triplicate. The relative expression (RE) of each gene in
rAd-transduced cells were calculated relative to that of β-actin
(REβ-actin) using the ΔCt method, i.e. REβ-actin=2
ΔCt, while
ΔCt= (Ctβ-actin−Cttarget gene). The normalized results were
represented as the number of fold changes when compared to
the rAd-Ctrl in each time point, which was calculated as log 2
[REβ-actin (rAd-S2 transduced)] log2 [REβ-actin (rAd-Ctrl
transduced)]−1.
MTT cell proliferation assay
Cell proliferation in rAd-transduced Vero E6 cells was
evaluated in a time- and dose-dependent manner using MTT
Cell Proliferation Kit (Roche) according to manufacturer's
instructions. Briefly, 1×104 Vero E6 cells were seeded in each
well of a 96-well tissue culture plate (Falcon) 1 day before rAd
transduction at the indicated MOIs. To assess the extent of cell
proliferation, MTT labeling reagent was added in the indicated
time points at a final concentration of 0.5 mg ml−1 and the plate
was incubated at 37 °C in dark for 4 h before the addition of
solubilization solution. The plate was then allowed to stand
overnight before the measurement of absorbance at 595 nm.
Bcl-xL co-transduction assay
Recombinant adenovirus carrying Bcl-xL (rAd-Bcl-xL) was
cloned, propagated and purified in the same way of other rAds
as described, whereas the Bcl-xL transgene was cloned from the
cDNA of Vero E6 cells. The expression of Bcl-xL in rAd-Bcl-
xL-transduced Vero E6 cells was confirmed by Western blot
targeting the transgene's V5 tag (data not shown). Ten thousand
cells were seeded 1 day before transduction. Serial diluted rAd-
Bcl-xL was then added to the cells 30 min before the trans-
duction of other candidate rAds at 50 MOI. After an incubation
for another 1.5 h, EMEM was added to each well to achieve a
final concentration of 1% FBS.
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